The Valley Desk

Clinical trial reportEuropean journal of cancer (Oxford, England : 1990)Published

Assessing time to symptomatic progression, a patient-relevant efficacy endpoint, in the MARIPOSA study in non-small cell lung cancer

15 of 31 authors shown in byline order.

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Clinical trial report
Venue
European journal of cancer (Oxford, England : 1990)
Published
Subject terms
Humans; Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Disease Progression; Acrylamides; Aniline Compounds; Pyrimidines; Indoles; Quinolines; Antineoplastic Combined Chemotherapy Protocols; Treatment Outcome; Time Factors
PubMed ID
42492306
Added to directory
Source checked

Report a correction or request removal